Executive Directors

Mr. KAM Yuen (甘源), is the Founder of the Group and an Executive Director of the Company. Mr. Kam is also a director of several subsidiaries of the Company. Previously he was also the chairman of Global Cord Blood Corporation and the non-executive director of Life Corporation Limited. He is responsible for the Group’s overall strategic planning. Mr. Kam graduated from the Beijing Second Foreign Languages Institute, the People’s Republic of China (北京第二外國語學院) in 1985 and has over 20 years of management experience in international business.

Mr. FENG Wen (馮文), is an Executive Director of the Company. Mr. Feng graduated from the Medical Department of the Third Military Medical University in 1992 and obtained a master’s degree from the School of Public Administration, Renmin University of China (中國人民大學) in 2006. He joined the Group in September 2012. Mr. Feng is currently the chairman of the board of Zhong He Hou De Investment Management Co., Ltd (中和厚德投資管理有限公司) and an independent director of Beijing ConST Instruments Technology Inc. (北京康斯特儀表科技股份有限公司). He was previously an independent director of Beijing Boer Communication Technology Co., Ltd. (北京玻爾通信技術股份有限公司), a chief executive officer of National Investments Fund Limited, a company listed on The Stock Exchange of Hong Kong Limited, and the secretary to the board of directors of China Investment Development Co., Ltd. (中投發展有限責任公司). Mr. Feng had worked for the General Office of the Ministry of Health of the PRC and a number of military hospitals for over 20 years.

Mr. LEONG Kim Chuan (梁金泉), is an Executive Director of the Company. Mr. Leong graduated from Tunku Abdul Rahman University College in 1994. He joined the Group in 2006. During August 2007 to November 2014, Mr. Leong also served as chief financial controller of the largest Chinese medicine retail chain in the United Kingdom and Republic of Ireland, and a leading consumer products retail chain listed on the NASDAQ. He is a director of GM Hospital Management (China) Company Limited, a wholly-owned subsidiary of the Company, and Seragaki Okinawa Joint Venture Limited, a joint venture of the Company. Mr. Leong was appointed as Deputy Chief Financial Officer of the Company in 2015, and is responsible for the Group’s finances and corporate projects. Prior to joining the Group, Mr. Leong worked with a number of leading international accounting firms. Mr. Leong is a member of The Association of Chartered Certified Accountants.

Independent Non-executive Directors

Mr. GAO Yue (高悅), is an Independent Non-Executive Director of the Company. Mr. Gao was redesignated from a Non-Executive Director to an Independent Non-Executive Director and appointed as a member and the chairman of the Nomination Committee and a member of the Audit Committee and the Remuneration Committee in April 2018. Mr. Gao graduated from the Law School of Renmin University of China (中國人民大學) in 1996 and was admitted to the Chinese bar in 1998. Thereafter, Mr. Gao worked as an attorney-at-law and a partner in Beijing Xinli Law Firm and Beijing Fu Sheng Law Firm respectively. From August 2004 to April 2012, he practised law as a partner in King & Wood PRC Lawyers. Mr. Gao joined the Group in November 2014. From May 2012 to July 2016, Mr. Gao worked as a partner of Commerce and Finance Law Offices. From July 2016 onwards, Mr. Gao has been served as a partner of 北京安生律師事務所 (formerly known as Beijing L&L Law Firm).

Mr. Daniel FOA, is an Independent Non-Executive Director of the Company. Mr. Foa was appointed as a member and the chairman of the Remuneration Committee and a member of the Audit Committee and the Nomination Committee in May 2019. Mr. Foa graduated in Economics from University of Portsmouth in 1997. He joined the Group in February 2015. Mr. Foa is the co-founder of Fairklima Capital and has over 20 years of experience in the China market with expertise in the fields of technology, sustainability and business consulting. Before founding Fairklima Capital, Mr. Foa held managerial positions in major multinational firms. He is also the co-founder of 51Give, an online donations platform.

Technology Development Advisory Board

The Group established a technology development advisory board (the "Technology Board") in 2000.The Technology Board comprised more than 40 experienced medical officers. The primary responsibilities of the Technology Board are (i) to develop the Group's key technology strategies; (ii) to monitor the progress of major technology programmes; and (iii) to review proposals for the development of new products and production technologies.

Senior Management

Mr. HUANG Fan (黄帆), is chief executive officer of the medical devices operation. He joined the Group in 2004 and has been responsible for the research and development, production, sales and management of the business. Mr. Huang has been engaged in the securities industry for many years and has extensive experience in business management. Prior to joining the Group, he has participated in the preliminary preparatory works of state-owned comprehensive securities company. Mr. Huang graduated from the Beijing Institute of Technology (北京理工大學管理學院), majoring in management.

Mr. GAO Guang Pu (高光譜), Deputy General Manager of the medical devices operation. He joined the Group in October 1997, and is responsible for the production, operations and overall management of the medical devices operation. Mr. Gao is also responsible for various aspects of the production technology, including product standards, production procedures and technological improvements of the medical devices operation. Mr. Gao graduated from the English Language Department of Bejing Second Foreign Language Institute (北京第二外國語學院).

Mr. SHAO Bao Ping (邵寶平), chief executive officer of the Chinese herbal medicines operation, is in charge of the Chinese herbal medicines operation's daily operations. He joined the Group in August 2005. Mr. Shao obtained his master's degree from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (中國科學院上海藥物研究所) and has extensive work experience in the fields of pharmacology and herbal medicine. Mr. Shao has held key position in well-known enterprises in the PRC and has extensive corporate management experience.

Mr. JING Jian Zhong (經建中), is the Vice President of the Group, the chief executive officer of Golden Meditech (Shanghai) Company Limited and the Chief Representative of the Group's Office in Shanghai and is responsible for the overall operation of the Group. He joined the Group in May 2008. He graduated from the Shanghai University of Chinese Medicines and has 15 years of investment and business development experiences in healthcare industry in addition to 20 years of clinical practices and teaching.

Back to top